Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 4433 - 4440 of 12011 results
HIPAA Compliance in a National Emergency: What Does It Look Like in Real Life?
March 18, 2020| Blog| Viewpoint
In Massachusetts, Health Insurance Carriers are Responding to COVID-19 – And Employers Can Help Spread the Word
March 18, 2020| Blog| Viewpoint
Regulatory Update for NFA and FINRA Member Firms — COVID-19
March 18, 2020| Alert| Viewpoint
Locking Down the IP Community
March 18, 2020| News
FINRA Warns Member Firms of COVID-19 Related Cybersecurity Risks
March 18, 2020| Blog| Viewpoint
Congress Calls on FTC to Protect Americans from Price Gouging During COVID-19 Health Crisis
March 18, 2020| Blog| Viewpoint
Employer Guidance: Home Office Employment for Foreign Workers
March 18, 2020| Advisory| Viewpoint
Congress Loosens Telehealth Reimbursement Restrictions in Response to Coronavirus, but State Law Practice Requirements Remain
March 17, 2020| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|